Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 4 hours ago
Abivax rebounds from stock drop with safety data for much-hyped colitis prospect
about 4 hours ago
Abivax has recovered from a dent in its share price after unveiling...
FDA gene therapy regulator Vijay Kumar steps down from leadership role
about 4 hours ago
Vijay Kumar, the acting head of the FDA office that oversees new...
China approved the world’s first solid tumor CAR-T therapy. When will the US follow?
about 5 hours ago
CAR-T cell therapy has flourished since it was first used in 2010...
Vistagen fails another phase 3 social anxiety trial but spies path to market
about 5 hours ago
Vistagen’s social anxiety disorder drug candidate has flunked another phase 3 trial...
Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE from China’s Metis TechBio
about 7 hours ago
U.S.-based Boulevard Bio is paying $20 million upfront to China’s Metis TechBio...
BMS-backed Beeline 'putting worker bee mentality into effect' with $126M series A extension
about 8 hours ago
Just two and a half months after buzzing out of stealth with...
Praxis faces FDA decision delay as analysts point finger at agency layoffs
about 9 hours ago
The FDA has delayed a decision on the approval of Praxis Precision...
FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
1 day ago
Sobi’s plan to introduce a challenger to Amgen’s blockbuster gout drug Krystexxa...
BioCryst ends internal discovery programs, closes Alabama facility in pivot to cost-saving partnerships
1 day ago
After scrapping development on its diabetic macular edema treatment avoralstat last month...
Evommune’s phase 2b trial flops, ending challenge to Novartis in hives
1 day ago
A phase 2b trial of Evommune’s EVO756 has missed its primary endpoint...
United Therapeutics nabs FDA approval for donor-lung assessment device
1 day ago
United Therapeutics has been given a premarket approval from the FDA for...
Roche launches Axelios 1, its eagerly awaited gene sequencing rival to Illumina
1 day ago
Roche may have failed to buy out Illumina back in 2012, but...